Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2023
Source ID
10.1016/j.chembiol.2023.03.002

Entities

People

  • Alexandra E. Gould
  • Anne-Catrin Uhlemann
  • Anthony J. O'Donoghue
  • Barbara H Stokes
  • Caroline L. Ng
  • Charisse Flerida A Pasaje
  • Daniella S. Bick
  • David A. Fidock
  • Gang Lin
  • Hao Zhang
  • Heekuk Park
  • Ioanna Deni
  • Jacquin C Niles
  • Jehad Almaliti
  • Kate J. Fairhurst
  • Kurt E Ward
  • Laura A Kirkman
  • Matthew Bogyo
  • Maëlle Duffey
  • Paula C.a. Da Fonseca
  • Ryan K. Muir
  • Shirin Akbar
  • Tomas Yeo
  • Wenhu Zhan
  • William H. Gerwick
  • Yi Jing Liu

Organizations

  • Cornell University
  • Gates Foundation
  • Medicines for Malaria Venture
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • Takeda (United States)
  • United States Department of Defense
  • University of Glasgow
  • University of Nebraska Medical Center